1-1 of 1
John T. Brandt, MD
Close
Sort by
Journal Articles

A Phase II Study of the Safety and Efficacy of a Novel Oral fXa Inhibitor (LY517717) for the Prevention of Venous Thromboembolism Following TKR or THR.

Giancarlo Agnelli, MD, Sylvia K. Haas, MD, Kathryn A. Krueger, MD, Alun W. Bedding, B.Sc, John T. Brandt, MD
Journal: Blood
Blood (2005) 106 (11): 278.
https://doi.org/10.1182/blood.V106.11.278.278
Published: 2005